240 related articles for article (PubMed ID: 14566962)
1. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
2. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
Le Gall M; Grall D; Chambard JC; Pouysségur J; Van Obberghen-Schilling E
Oncogene; 1998 Sep; 17(10):1271-7. PubMed ID: 9771970
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of the cyclin-dependent kinase inhibitor P27 in primary hepatocytes in early-mid G1 and G1/S transitions.
McIntyre M; Desdouets C; Sénamaud-Beaufort C; Laurent-Winter C; Lamas E; Bréchot C
Oncogene; 1999 Aug; 18(32):4577-85. PubMed ID: 10467402
[TBL] [Abstract][Full Text] [Related]
4. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence.
Johnson D; Frame MC; Wyke JA
Oncogene; 1998 Apr; 16(15):2017-28. PubMed ID: 9591786
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cyclin D-dependent kinase activity in rat liver regeneration.
Kato A; Ota S; Bamba H; Wong RM; Ohmura E; Imai Y; Matsuzaki F
Biochem Biophys Res Commun; 1998 Apr; 245(1):70-4. PubMed ID: 9535785
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of the cell cycle--involvement of protein inhibitors of cyclin-dependent kinases].
Grzelakowska-Sztabert B
Postepy Biochem; 1995; 41(2):80-93. PubMed ID: 7479444
[No Abstract] [Full Text] [Related]
7. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide.
Chen G; Shu J; Stacey DW
Oncogene; 1997 Oct; 15(14):1643-51. PubMed ID: 9349497
[TBL] [Abstract][Full Text] [Related]
9. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
Cheng M; Sexl V; Sherr CJ; Roussel MF
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290
[TBL] [Abstract][Full Text] [Related]
10. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy.
Poolman RA; Brooks G
J Mol Cell Cardiol; 1998 Oct; 30(10):2121-35. PubMed ID: 9799664
[TBL] [Abstract][Full Text] [Related]
11. Sublytic complement attack induces cell cycle in oligodendrocytes.
Rus HG; Niculescu F; Shin ML
J Immunol; 1996 Jun; 156(12):4892-900. PubMed ID: 8648139
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation.
Bonapace IM; Addeo R; Altucci L; Cicatiello L; Bifulco M; Laezza C; Salzano S; Sica V; Bresciani F; Weisz A
Oncogene; 1996 Feb; 12(4):753-63. PubMed ID: 8632897
[TBL] [Abstract][Full Text] [Related]
13. Phenotype dictates the growth response of vascular smooth muscle cells to pulse pressure in vitro.
Cappadona C; Redmond EM; Theodorakis NG; McKillop IH; Hendrickson R; Chhabra A; Sitzmann JV; Cahill PA
Exp Cell Res; 1999 Jul; 250(1):174-86. PubMed ID: 10388531
[TBL] [Abstract][Full Text] [Related]
14. Threshold-dependent DNA synthesis by pure pressure in human aortic smooth muscle cells: Gialpha-dependent and -independent pathways.
Ozaki T; Iizuka K; Suzuki M; Murakami T; Kitabatake A; Kawaguchi H
Biochem Biophys Res Commun; 1999 Mar; 256(1):212-7. PubMed ID: 10066449
[TBL] [Abstract][Full Text] [Related]
15. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases.
Shim J; Lee H; Park J; Kim H; Choi EJ
Nature; 1996 Jun; 381(6585):804-6. PubMed ID: 8657286
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol, a multiple-action neurohumoral antagonist, inhibits mitogen-activated protein kinase and cell cycle progression in vascular smooth muscle cells.
Sung CP; Arleth AJ; Eichman C; Truneh A; Ohlstein EH
J Pharmacol Exp Ther; 1997 Nov; 283(2):910-7. PubMed ID: 9353413
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic acid and docosahexaenoic acid inhibit vascular smooth muscle cell proliferation by inhibiting phosphorylation of Cdk2-cyclinE complex.
Terano T; Tanaka T; Tamura Y; Kitagawa M; Higashi H; Saito Y; Hirai A
Biochem Biophys Res Commun; 1999 Jan; 254(2):502-6. PubMed ID: 9918868
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts.
Tomono M; Toyoshima K; Ito M; Amano H; Kiss Z
Arch Biochem Biophys; 1998 May; 353(2):374-8. PubMed ID: 9606972
[TBL] [Abstract][Full Text] [Related]
19. Modulation of mitogen-activated protein kinase activation and cell cycle regulators by the potent skin cancer preventive agent silymarin.
Zi X; Agarwal R
Biochem Biophys Res Commun; 1999 Sep; 263(2):528-36. PubMed ID: 10491326
[TBL] [Abstract][Full Text] [Related]
20. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells.
Ishida A; Sasaguri T; Kosaka C; Nojima H; Ogata J
J Biol Chem; 1997 Apr; 272(15):10050-7. PubMed ID: 9092548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
